End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -99.00% | -99.00% |
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 06-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 06-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 10,000,000 | 0 | 0 | 15.89 % |
Stock B | 1 | 2,586,326 | 2,000,000 ( 77.33 %) | 0 |
Company contact information
Synvista Therapeutics, Inc.
6 Campus Drive
07054, Parsippany
+
Sector
1st Jan change | Capi. | |
---|---|---|
-99.00% | 2 | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- SYNI Stock
- Company Synvista Therapeutics, Inc.